ctrl K

Watchlist Price Alert

Maze Therapeutics Inc. (MAZE)

NASDAQ: MAZE · Real-Time Price · USD

12.87

-0.47 (-3.52%)

At close: Jun 06, 2025, 3:59 PM

12.59

-2.18%

After-hours: Jun 06, 2025, 05:57 PM EDT

Maze Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	167.5M	n/a	n/a
Cost of Revenue	n/a	n/a	n/a
Gross Profit	167.5M	n/a	n/a
Operating Income	57.59M	-98.55M	-111.03M
Interest Income	4.65M	1.97M	2.03M
Pretax Income	53.4M	-100.42M	-114.94M
Net Income	52.23M	-100.42M	-114.94M
Selling & General & Admin	26.42M	24.61M	22.83M
Research & Development	83.5M	73.94M	88.19M
Other Expenses	n/a	n/a	n/a
Operating Expenses	109.91M	98.55M	111.03M
Interest Expense	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	109.91M	98.55M	111.03M
Income Tax Expense	1.17M	n/a	n/a
Shares Outstanding (Basic)	43.78M	34.97M	34.97M
Shares Outstanding (Diluted)	43.78M	35.4M	35.4M
EPS (Basic)	0.08	-2.87	-3.29
EPS (Diluted)	0.08	-2.87	-3.29
EBITDA	60.88M	-94.46M	-107.21M
EBIT	57.59M	-98.55M	-111.03M
Depreciation & Amortization	3.3M	4.09M	3.82M